Clinical Trails registered on ClinicalTrials.gov - Accessed 27th January, 2017 Rank Status Study Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer 1 Unknown Condition: Hepatocellular Cancer Interventions: Drug: Sorafenib; Radiation: yttrium-90 radioembolization Holmium-166-radioembolization in NET After Lutetium-177-dotatate; an Efficacy Study 2 Recruiting Condition: Neuroendocrine Tumors Intervention: Device: Holmium-166 microspheres hepatic radioembolization. Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases 3 Active, not recruiting Condition: Neuroendocrine Tumors Drug: Pasireotide; Procedure: Sir-sphere Radioembolization; Interventions: Drug: Everolimus Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma 4 Recruiting Condition: Hepatocellular Carcinoma Procedure: Transarterial Radioembolization; Procedure: Interventions: Transarterial Chemoembolization using drug-eluting beads Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma 5 Recruiting Condition: HepatoCellular Carcinoma Interventions: Radiation: Y-90 Radioembolization; Drug: Nivolumab Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases 6 Recruiting Conditions: Colon Cancer; Rectal Cancer; Liver Metastases Interventions: Drug: Tas-102; Device: SIR-Sphere Feasibility of Single Session In-Room Yttrium-90 Radioembolization Diagnostic Angiography and Treatment 7 Recruiting Conditions: Malignant Neoplasms of Digestive Organs; Metastatic Liver Tumors Intervention: Device: SIR-Spheres Local Ablative Strategies After Endovascular Radioembolization (LASER) Condition: Metastatic Colorectal Cancer 8 Recruiting Device: PET/MRI; Radiation: Percutaneous microwave ablation; Interventions: Radiation: Stereotactic body radiotherapy Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma Condition: Ocular Melanoma 9 Recruiting Drug: Sorafenib; Device: Radioembolization with SIR-Spheres® Interventions: (Yttrium Microspheres) PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Metastatic Extrahepatic Bile Duct Cancer; 10 Active, not recruiting Conditions: Recurrent Adult Primary Liver Cancer; Recurrent Extrahepatic Bile Duct Cancer; Stage D Adult Primary Liver Cancer (BCLC); Unspecified Adult Solid Tumor, Protocol Specific Procedure: PET scan; Procedure: CT Scan; Interventions: Procedure: hepatic artery embolization Metastatic Colorectal Cancer Liver Metastases Outcomes After Resin 90Y Microsphere Radioembolization in the USA Evaluation Project 11 Unknown † Conditions: Colorectal Cancer; Liver Metastases Intervention: Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC) 12 Recruiting Condition: Hepatocellular Carcinoma Interventions: Drug: TACE-DEB; Drug: 90Y-RE Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization Colorectal Neoplasms; Neoplasm Metastasis; Liver Diseases; 13 Recruiting Conditions: Digestive System Neoplasms Intervention: Device: Holmium-166-poly (L-lactic acid) microspheres Microsphere Localization Using Image Result for Positron Emission Tomography-Magnetic Resonance Imaging (PET/MRI) or Positron Emission Tomography-Computed Tomography (PET/CT) in Patients With 14 Recruiting Liver Disease Condition: Liver Neoplasms Interventions: Device: PET/MR; Device: PET/CT Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres 15 Not yet recruiting Neuroendocrine Tumors; Gastrointestinal Neoplasms; Conditions: Carcinoid Tumors Interventions: Drug: Lanreotide; Device: Y-90 microspheres Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases 16 Recruiting Condition: Colorectal Neoplasms Interventions: Device: SIR-Spheres; Drug: Regorafenib Pair Production PET Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 Radioembolization 17 Active, not recruiting Condition: Carcinoma, Hepatocellular Intervention: Prospective Post Y90 Liver Hypertrophy 18 Recruiting Conditions: Hepatocellular Carcinoma; Liver Hypertrophy Intervention: Other: CT volumetric measurement after Y90 radioembolization Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT Advanced Adult Primary Liver Cancer; Liver Metastases; Conditions: Localized Unresectable Adult Primary Liver Cancer; 19 Active, not recruiting Recurrent Adult Primary Liver Cancer Procedure: positron emission tomography; Interventions: Procedure: computed tomography Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis 20 Recruiting Condition: Uveal Melanoma Interventions: Procedure: SIRT; Procedure: DSM-TACE Correlation Between CT Perfusion and Post Y-90 TARE PET/CT Dosimetry 21 Recruiting Condition: Hepatocellular Carcinoma Interventions: Radiation: CT Liver Perfusion; Radiation: PET/CT of liver Interest of Functional MRI (Magnetic Resonance Imagery) (in Patients Suffering From Hepatocellular Carcinoma and Treated With Yttrium 22 Recruiting Condition: Hepatocellular Carcinoma Intervention: Other: Additional RMIs Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver 23 Active, not recruiting Condition: Hepatocellular Carcinoma Interventions: Procedure: RFA; Procedure: Radioembolization (SIRT) CIRSE Registry for SIR-Spheres Therapy Condition: Liver Carcinoma 24 Recruiting Device: Yttrium-90 loaded SIR-Spheres microspheres; Interventions: Behavioral: QLQ-C30 with HCC module 90Y Transarterial Radioembolization (TARE) Plus Gemcitabine and Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma 25 Recruiting Condition: Intrahepatic Cholangiocarcinoma Device: SIR-Spheres microspheres (Yttrium-90 Microspheres); Interventions: Drug: Gemcitabine; Drug: Cisplatin Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal Cancer 26 Recruiting Condition: Colorectal Cancer Device: HAI-90Y radioembolization (SIR-spheres injection); Interventions: Drug: systemic chemotherapy LV5FU2 Lung Dose in Patients Treated With Yttrium-90 for Hepatocellular Carcinoma 27 Recruiting Condition: Liver Neoplasms Intervention: Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver Metastatic Carcinoma in the Liver; MLH1 Gene Mutation; MSH6 Gene Mutation; PMS2 Gene Mutation; 28 Not yet recruiting Conditions: Stage IV Colorectal Cancer; Stage IVA Colorectal Cancer; Stage IVB Colorectal Cancer Biological: Durvalumab; Other: Laboratory Biomarker Analysis; Interventions: Biological: Tremelimumab Definitive Therapy for Oligometastatic Solid Malignancies Condition: Stage IV or Recurrent Carcinoma or Sarcoma Procedure: Complete Surgical Removal; 29 Recruiting Radiation: Stereotactic Radiosurgery; Interventions: Radiation: Ablative external beam radiation dose; Procedure: Subtotal surgical removal plus ablative radiation dose; Radiation: Radioembolization Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma 30 Active, not recruiting Condition: Cholangiocarcinoma Radiation: Therasphere® in association with Gemcitabine and Intervention: Cisplatin Internal Radiation Therapy for Hepatocellular Carcinomas With Therasphere: Optimized Dosimetry Versus Standard Dosimetry 31 Recruiting Condition: Adenoma, Liver Cell Radiation: Optimized Internal Radiation Therapy; Interventions: Radiation: Standard Internal Radiation Therapy Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC). 32 Unknown Condition: Intrahepatic Cholangiocellular Carcinoma Interventions: Procedure: DEB TACE; Procedure: SIRT PERfusion CT in the FOXFIRE Trial to Study Blood Flow to Liver Metastases 33 Unknown Condition: Metastatic Colorectal Cancer Intervention: Other: Perfusion CT scan Prospective Tumor Response Evaluation Conditions: Hepatocellular Cancer; Metastatic Liver Cancer 34 Recruiting Procedure: TACE; Procedure: Y-90; Procedure: MWA; Interventions: Procedure: IRE Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma 35 Recruiting Condition: Hepatocellular Carcinoma Procedure: Transarterial Radioembolization; Procedure: Interventions: Transarterial Chemoembolization using drug-eluting beads Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer 36 Unknown Condition: Hepatocellular Cancer Interventions: Drug: Sorafenib; Radiation: yttrium-90 radioembolization Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC) 37 Recruiting Condition: Hepatocellular Carcinoma Interventions: Drug: TACE-DEB; Drug: 90Y-RE 90Y Transarterial Radioembolization (TARE) Plus Gemcitabine and Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma 38 Recruiting Condition: Intrahepatic Cholangiocarcinoma Device: SIR-Spheres microspheres (Yttrium-90 Microspheres); Interventions: Drug: Gemcitabine; Drug: Cisplatin Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis 39 Recruiting Condition: Uveal Melanoma Interventions: Procedure: SIRT; Procedure: DSM-TACE Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC). 40 Unknown Condition: Intrahepatic Cholangiocellular Carcinoma Interventions: Procedure: DEB TACE; Procedure: SIRT 90Y Transarterial Radioembolization (TARE) Plus Gemcitabine and Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma 41 Recruiting Condition: Intrahepatic Cholangiocarcinoma Device: SIR-Spheres microspheres (Yttrium-90 Microspheres); Interventions: Drug: Gemcitabine; Drug: Cisplatin 11C-Choline PET/CT and DWI MRI for Response Assessment of HCC Candidate to TARE 42 Recruiting Condition: Hepatocarcinoma Intervention: Other: No intervention Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Carcinoma 43 Recruiting Condition: Hepatocellular Carcinoma Procedure: Transarterial Radioembolization; Procedure: Interventions: Transarterial Chemoembolization using drug-eluting beads Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer 44 Unknown Condition: Hepatocellular Cancer Interventions: Drug: Sorafenib; Radiation: yttrium-90 radioembolization Correlation Between CT Perfusion and Post Y-90 TARE PET/CT Dosimetry 45 Recruiting Condition: Hepatocellular Carcinoma Interventions: Radiation: CT Liver Perfusion; Radiation: PET/CT of liver Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment Condition: Intrahepatic Cholangiocellular Carcinoma 46 Unknown Interventions: Procedure: DEB TACE; Procedure: SIRT Treatment for Bile Duct Cancer in the Liver 47 Recruiting Condition: Cholangio Carcinoma Intervention: Drug: SIRT Yttrium-90 Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced 48 Active, not recruiting Condition: Hepatocellular Carcinoma Interventions: Device: SIR-Spheres; Drug: Sorafenib tosylate Internal Radiation Therapy for Hepatocellular Carcinomas With Therasphere: Optimized Dosimetry Versus Condition: Adenoma, Liver Cell 49 Recruiting Radiation: Optimized Internal Radiation Therapy; Interventions: Radiation: Standard Internal Radiation Therapy CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases 50 Active, not recruiting Condition: Liver Metastases Interventions: Biological: anti-CEA CAR-T cells; Device: Sir-Spheres SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Condition: Intrahepatic Cholangiocarcinoma 51 Not yet recruiting Drug: Cisplatin-gemcitabine; Device: Radiation: SIRT + chemotherapy Interventions: (cisplatin-gemcitabine) Prospective Post Y90 Liver Hypertrophy 52 Recruiting Conditions: Hepatocellular Carcinoma; Liver Hypertrophy Intervention: Other: CT volumetric measurement after Y90 radioembolization CIRSE Registry for SIR-Spheres Therapy Condition: Liver Carcinoma 53 Recruiting Device: Yttrium-90 loaded SIR-Spheres microspheres; Interventions: Behavioral: QLQ-C30 with HCC module Study of Y90-Radioembolization With Nivolumab in Asians With Hepatocellular Carcinoma 54 Recruiting Condition: HepatoCellular Carcinoma Interventions: Radiation: Y-90 Radioembolization; Drug: Nivolumab FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary 55 Active, not recruiting Condition: Colorectal Cancer Metastatic Interventions: Drug: FOLFOX6m; Device: SIR-Spheres microspheres Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Conditions: Metastatic Cancer; Pancreatic Cancer 56 Unknown Drug: fluorouracil; Radiation: selective external radiation therapy; Interventions: Radiation: tomotherapy; Radiation: yttrium Y 90 glass microspheres; Radiation: yttrium Y 90 resin microspheres Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Neuroendocrine Tumors; Gastrointestinal Neoplasms; 57 Not yet recruiting Conditions: Carcinoid Tumors Interventions: Drug: Lanreotide; Device: Y-90 microspheres SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver 58 Recruiting Condition: Stage IV Uveal Melanoma Intervention: Device: Sir-Spheres® Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT Advanced Adult Primary Liver Cancer; Liver Metastases; Conditions: Localized Unresectable Adult Primary Liver Cancer; 59 Active, not recruiting Recurrent Adult Primary Liver Cancer Procedure: positron emission tomography; Interventions: Procedure: computed tomography Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein 60 Active, not recruiting Condition: Hepatocellular Carcinoma Interventions: Device: TheraSphere; Drug: Sorafenib Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or 61 Active, not recruiting Conditions: Liver Cancer; Metastatic Cancer Interventions: Drug: capecitabine; Radiation: yttrium Y 90 glass microspheres Lung Dose in Patients Treated With Yttrium-90 for Hepatocellular Carcinoma 62 Recruiting Condition: Liver Neoplasms Intervention: Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced 63 Active, not recruiting Condition: Hepatocellular Carcinoma Interventions: Device: SIR-Spheres; Drug: Sorafenib tosylate Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma 64 Recruiting Condition: Uveal Melanoma Interventions: Procedure: SIRT; Procedure: DSM-TACE Sorafenib and Yttrium-90 Glass Microspheres for Advanced Hepatocellular Carcinoma (HCC) Condition: Liver Cancer 65 Recruiting Drug: Sorafenib; Radiation: Yttrium-90 Microspheres; Interventions: Behavioral: Follow-Up Phone Calls CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases 66 Active, not recruiting Condition: Liver Metastases Interventions: Biological: anti-CEA CAR-T cells; Device: Sir-Spheres FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Conditions: Colorectal Cancer; Colorectal Carcinoma; Liver Metastases 67 Active, not recruiting Drug: Systemic chemotherapy (FOLFOX); Device: SIR- Interventions: Spheres yttrium-90 microspheres Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer 68 Recruiting Condition: Unresectable Hepatocellular Carcinoma Intervention: Device: TheraSphere Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal 69 Recruiting Condition: Colorectal Cancer Metastatic Intervention: Device: TheraSphere Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be 70 Unknown Condition: Liver Cancer Intervention: Radiation: yttrium Y 90 glass microspheres 90Y Transarterial Radioembolization (TARE) Plus Gemcitabine and Cisplatin in Unresectable Intrahepatic Condition: Intrahepatic Cholangiocarcinoma 71 Recruiting Device: SIR-Spheres microspheres (Yttrium-90 Microspheres); Interventions: Drug: Gemcitabine; Drug: Cisplatin Internal Radiation Therapy for Hepatocellular Carcinomas With Therasphere: Optimized Dosimetry Versus Condition: Adenoma, Liver Cell 72 Recruiting Radiation: Optimized Internal Radiation Therapy; Interventions: Radiation: Standard Internal Radiation Therapy Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular 73 Recruiting Condition: Hepatocellular Carcinoma Interventions: Drug: TACE-DEB; Drug: 90Y-RE Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases Conditions: Uveal Melanoma; Hepatic Metastases 74 Recruiting Device: SIR-Spheres® Yttrium 90; Drug: ipilimumab; Interventions: Drug: nivolumab Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver 75 Recruiting Conditions: Colon Cancer; Rectal Cancer; Liver Metastases Interventions: Drug: Tas-102; Device: SIR-Sphere Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study 76 Recruiting Condition: Localized Non-Resectable Adult Liver Carcinoma Intervention: Other: Yttrium-90 Resin Microspheres Nivolumab and Yttrium Y 90 Glass Microspheres in Treating Patients With Advanced Liver Cancer Stage IIIA Hepatocellular Carcinoma; Stage IIIB Hepatocellular Carcinoma; Conditions: Stage IIIC Hepatocellular Carcinoma; 77 Recruiting Stage IVA Hepatocellular Carcinoma; Stage IVB Hepatocellular Carcinoma Other: Laboratory Biomarker Analysis; Biological: Nivolumab; Interventions: Radiation: Yttrium Y 90 Glass Microspheres Metastatic Colorectal Cancer Liver Metastases Outcomes After Resin 90Y Microsphere Radioembolization 78 Unknown Conditions: Colorectal Cancer; Liver Metastases Intervention: Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal Condition: Colorectal Cancer 79 Recruiting Device: HAI-90Y radioembolization (SIR-spheres injection); Interventions: Drug: systemic chemotherapy LV5FU2 Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With 80 Recruiting Condition: Colorectal Neoplasms Interventions: Device: SIR-Spheres; Drug: Regorafenib Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced 81 Unknown Condition: Hepatocellular Cancer Interventions: Drug: Sorafenib; Radiation: yttrium-90 radioembolization Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Condition: Cholangiocarcinoma 82 Active, not recruiting Intervention: Radiation: Therasphere® in association with Gemcitabine and Cisplatin Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Conditions: 83 Recruiting Localized Unresectable Adult Primary Liver Cancer; Recurrent Adult Primary Liver Cancer Radiation: yttrium Y 90 glass microspheres; Interventions: Other: laboratory biomarker analysis SIRT Followed by CIS-GEM Chemotherapy Versus CIS-GEM Chemotherapy Alone as 1st Line Treatment of Condition: Intrahepatic Cholangiocarcinoma 84 Not yet recruiting Drug: Cisplatin-gemcitabine; Device: Radiation: SIRT + chemotherapy Interventions: (cisplatin-gemcitabine) Microsphere Localization Using Image Result for Positron Emission Tomography-Magnetic Resonance 85 Recruiting Condition: Liver Neoplasms Interventions: Device: PET/MR; Device: PET/CT Treatment for Bile Duct Cancer in the Liver 86 Recruiting Condition: Cholangio Carcinoma Intervention: Drug: SIRT Yttrium-90 Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors 87 Unknown Condition: Liver Neoplasms Intervention: Device: TheraSphere, Yttrium-90 glass Microspheres Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Conditions: Metastatic Cancer; Pancreatic Cancer 88 Unknown Drug: fluorouracil; Radiation: selective external radiation therapy; Interventions: Radiation: tomotherapy; Radiation: yttrium Y 90 glass microspheres; Radiation: yttrium Y 90 resin microspheres Radiolabeled Glass Beads Used for Treating Patients With Primary Liver Cancer When Surgery is Not an 89 Enrolling by invitation Conditions: Liver Cancer; Hepatoma Intervention: Device: Yttrium 90 (TheraSphere) Humanitarian Device Exemption (HDE) Treatment Protocol For Treatment of Unresectable Hepatocellular 90 Recruiting Conditions: Carcinoma, Hepatocellular; Liver Cancer Intervention: Device: TheraSphere Treatment Radiolabeled Glass Beads in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by 91 Recruiting Conditions: Liver Cancer; Metastatic Cancer Intervention: Radiation: Yttrium Y 90 glass microspheres Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery 92 Recruiting Condition: Liver Cancer Intervention: Radiation: yttrium Y 90 glass microspheres Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Conditions: Colorectal Cancer; Metastatic Cancer 93 Unknown Drug: floxuridine; Drug: fluorouracil; Drug: irinotecan hydrochloride; Interventions: Drug: leucovorin calcium; Drug: oxaliplatin Transarterial Radioembolization Versus Chemoembolization for the Treatment of Hepatocellular Condition: Hepatocellular Carcinoma 94 Recruiting Procedure: Transarterial Radioembolization; Procedure: Transarterial Interventions: Chemoembolization using drug-eluting beads